PBR Life Sciences is a startup that has received $1 million in pre-seed funding. This investment will assist the firm in expanding its unique solutions. It relies on big data and AI to address significant healthcare issues, particularly in Africa and other emergent economies.
The given mission statement challenges the company to contribute to cutting the billions of dollars wasted on expired pharmaceutical products in Africa. The challenge comes from the fact that the market price data is static, making supply chain management difficult.
Big data is to be collected and analyzed using AI to produce meaningful tools for the enhancement of the effectiveness of the healthcare system.
Challenges that Investors Face in Emerging Markets
Some challenges come with operating in emerging markets, more so in the African region. It also includes uninformed, enterprise-wide, unformatted, and undeveloped data.
PBR Life Sciences has continued to persist in achieving its goals of formulating sustainable models in the healthcare systems in these areas of the world.
Growing Together: A Fondness for Partnership
PBR Life Sciences has lined up user-based funds from its key investors. It includes Launch Africa Ventures, Microtraction, and Techstars It will enable PBR Life Sciences to take its Data-as-a-Service and analytics platform to Nigeria, Ghana, as well as Kenya.
It will benefit pharma businesses, health tech companies, universities, and other stakeholders in the industry to make informed decisions that enhance aspects.
